Drug Discovery World

AUGUST 22, 2023

Originator pharma companies are developing ever more complex products, which are transforming the medical landscape, but their cost places an increasing burden on healthcare budgets worldwide. Opportunities Originator pharma companies are developing more and more complex products these days.

Production 130

Production Pharma Companies Clinical Trials FDA 130

Drug Discovery World

JULY 18, 2022

Troy Groetken of intellectual property and technology law firm McAndrews, Held & Malloy tells Lu Rahman how pharma companies can take this data from where it currently stands (drug design and development) to a more clinical level. Groetken sees many opportunities to utilise big data and AI in pharma.

Clinical Trials 130

Clinical Trials Therapies Pharmaceuticals Science 130

Drug Discovery World

NOVEMBER 16, 2022

Here, DDW’s Reece Armstrong speaks to Dan O’Connor, VP of drug discovery at Molecular Devices, about what the OIC offers to pharmaceutical companies and the advantages and barriers of 3D biology. . 2D biology has been used by pharmaceutical researchers for decades. The benefits to drug development are obvious then.

Pharma Companies 243

Pharma Companies Science Research Drugs 243

Predictive Oncology

FEBRUARY 7, 2023

That means a lot of wasted effort and resources for drugmakers given that even before a molecule enters Phase I trials, typically five to eight years of development have already been invested in the product. The next step was to validate the predictions and learn whether the drugs really produce a response in the specific tumor type.

Clinical Trials 52

Clinical Trials Pharmaceutical Companies Trials Pharmaceuticals 52

Alta Sciences

MARCH 27, 2024

Up Close and Personal With Eryn Corriveau, MSc, Senior Director, Drug Development and Regulatory Strategy nbartlett Wed, 03/27/2024 - 20:21 Here at Altasciences, Eryn is responsible for guiding regulatory strategies , conducting gap analyses, and leading interactions with regulatory agencies dur ing early drug development.

Drug Development 52

Drug Development Medical Schools Pharma Companies Drugs 52

DrugBank

JUNE 27, 2024

Drug repurposing is an approach that, while not new, has become popular in the last decade. Generic drugs are also an interesting case and are common targets for repurposing due to their established safety profiles and long market presence.

Drugs 71

Drugs Pharma Companies Computational Chemistry Clinical Trials 71

Drug Discovery World

MAY 7, 2024

And it won’t be a quick move back into this market, by those big companies, but I think we need to keep pushing them.” The healthcare sector is trying to make it more appealing for pharma companies to develop antimicrobials. They don’t see it. They don’t respond to it.

Vaccine 147

Vaccine Pharmaceutical Companies Clinical Trials Trials 147

Drug Discovery World

AUGUST 10, 2023

Remco Munnik (RM): Up to now, regulatory has always been the spider in the web within a pharmaceutical company – collecting all of the relevant information for submission of the registration: Clinical, CMC, administrative data, etc – then compiling a valid eCTD by the submission deadline.

Pharmaceutical Companies 245

Pharmaceutical Companies Production Science Pharma Companies 245

Drug Discovery World

JANUARY 26, 2023

DDW Editor Reece Armstrong takes a look at the pharmaceutical research and development market in 2023 and asks key opinion leaders what challenges and trends will emerge throughout the year. As such, 2022 saw a marked fall in ROI for global pharmaceutical companies and their research and development activities.

Clinical Trials 246

Clinical Trials Drugs Trials Therapies 246

Drug Discovery World

NOVEMBER 15, 2022

If a pharmaceutical company is racing to identify a new vaccine, for instance, then waiting for three weeks to receive DNA sequences each time can slow down the development process compared to competitors who might have faster timelines.” . Synthetic libraries for antibody drug discovery .

DNA 246

DNA Engineering Drugs Vaccine 246

Altus Drug Development

JUNE 28, 2022

Ensuring access to safe and effective treatments is the main challenge faced by pharmaceutical companies big and small. Value-added medicines offer an efficient method to meet the needs of patients while stimulating innovation in the pharmaceutical industry. Accomplished repositioned drugs may be used for future repositions.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Doctors Production 52

Drug Target Review

MAY 23, 2023

Algae – an overlooked resource for new therapies It is only in recent years that algae research has expanded beyond their potential for producing biodiesel, to also consider them as a bio-resource, not only for novel prebiotics but also for compounds with unique structures and pharmaceutically relevant bioactivities.

Small Molecule 75

Small Molecule Drugs Production Pharma Companies 75

Drug Discovery World

AUGUST 16, 2022

These observations may come to light in the clinic, but these disparities can be attributed to every phase of the drug development pipeline – clinical trials, translational research and, ultimately, drug discovery. . Cancer health disparities and underlying contributing factors . Underrepresentation in the workforce .

Research 130

Research Clinical Trials Trials Drug Development 130

Elrig

APRIL 29, 2024

Harini Srinivasan is a Principal Scientific Associate at Serna Bio with over 10 years of research experience in academic institutions, health care organizations and pharmaceutical companies. big pharma or startups/spin off? thanks Big pharma experienced is very well respected within biotech or small-startups.

Bioinformatics 59

Bioinformatics Molecular Biology Drugs Cell Based Assays 59

Codon

FEBRUARY 13, 2024

The weakened dose of phages helped bacteria develop resistance, and the trial became yet another study that provided evidence phages are safe, but little more. These factors led d’Herelle to try and defect to the Soviet Union, which at the time was investing in enormous, nationalized healthcare infrastructure.

Therapies 128

Therapies DNA Virus Clinical Trials 128

Drug Discovery World

SEPTEMBER 7, 2022

The drug discovery and development process is costly and arduous, offering no certainty of success which often rests on whether a company has chosen the correct drug molecule and target. With its use scattered across the industry, just how are researchers utilising AI to improve drug discovery? .

Research 130

Research Clinical Trials Pharmaceutical Companies Pharma Companies 130

The Pharma Data

DECEMBER 30, 2020

. Another Biden plan opens up foreign markets for consumers to buy their prescription drugs and calls for limiting price increases on branded drugs and generics for drugs included in the Medicare program. Four big companies are cited as possible tasty takeover targets for 2021. The company has a market cap of $15.4

Vaccine 52

Vaccine FDA Trials Therapies 52